CLINICAL_TRIALS
trial_result
· 2017-11-06
Clinical Trial Update: Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function [Phase 1]
Summary
Phase 1 pharmacokinetic study of an inhaled corticosteroid in asthma patients with impaired liver function to evaluate how liver dysfunction affects drug exposu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED